Dr. Buffington on MRI Fusion for Prostate Cancer

Video

Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses MRI fusion-guided biopsy in patients with prostate cancer.

Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses MRI fusion-guided biopsy in patients with prostate cancer.

MRI fusion is done in many groups for the second biopsy for patients with prostate cancer, Buffington explains. A patient receiving MRI fusion is either on active surveillance with known prostate cancer or had a negative biopsy in the past but their prostate-specific antigen (PSA) is still rising.

The MRI is not so much for screening but helps target an area that may have been missed on a prior biopsy. A patient receives an MRI and if there is a concerning area the physicians take those images and fuse it with the images from the ultrasound to better target the area and biopsy it, says Buffington.

Related Videos
Joseph G. Jurcic, MD
Zeynep Eroglu, MD
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles